A new mathematical model for optimizing the combination between antiangiogenic and cytotoxic drugs in oncology

DOI10.1016/J.CRMA.2011.11.019zbMath1232.92052OpenAlexW1985436946MaRDI QIDQ664918

Joseph Ciccolini, Guillemette Chapuisat, Sébastien Benzekry, Florence Hubert, Alice Erlinger

Publication date: 5 March 2012

Published in: Comptes Rendus. Mathématique. Académie des Sciences, Paris (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.crma.2011.11.019

Mathematics Subject Classification ID

Dynamical systems in biology (37N25) Medical applications (general) (92C50) General theory for ordinary differential equations (34A99)

Related Items (7)

Mathematical model of cancer growth controled by metronomic chemotherapies ⋮ Transient alleviation of tumor hypoxia during first days of antiangiogenic therapy as a result of therapy-induced alterations in nutrient supply and tumor metabolism -- analysis by mathematical modeling ⋮ Mathematical modelling of chemotherapy combined with bevacizumab ⋮ Optimizing the delivery of combination therapy for tumors: A mathematical model ⋮ Maximum tolerated dose versus metronomic scheduling in the treatment of metastatic cancers ⋮ Combined therapy for treating solid tumors with chemotherapy and angiogenic inhibitors ⋮ A novel numerical and artificial intelligence based approach to study anti-angiogenic drugs: endostatin

Cites Work

• Mathematical and numerical analysis for a model of growing metastatic tumors
• Mathematical and numerical analysis of a model for anti-angiogenic therapy in metastatic cancers
• Modeling the Impact of Anticancer Agents on Metastatic Spreading

This page was built for publication: A new mathematical model for optimizing the combination between antiangiogenic and cytotoxic drugs in oncology